Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Plasma-Lyte A is a sterile, isotonic, nonpyrogenic multiple electrolyte injection solution developed by Baxter International. It is designed to mimic the electrolyte composition of human plasma, with a pH of 7.4. The solution contains sodium chloride, sodium gluconate, sodium acetate trihydrate, potassium chloride, and magnesium chloride. It serves as a source of water and electrolytes and acts as an alkalinizing agent due to the presence of acetate and gluconate, which are hydrogen ion acceptors. It is primarily indicated for the treatment of dehydration and electrolyte imbalance, as well as for general irrigation, rinsing, and washing during surgical procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium chloride + sodium chloride + sodium gluconate + sodium acetate + potassium chloride.